Background Venous thromboembolism (VTE) remains the third leading cause of acute
cardiovascular syndrome following myocardial infarction and ischemic stroke. The global …

Pulmonary hypertension (PH) was once a devastating and fatal disease entity, the outlook of
which has been significantly improved by the continued progress of medical treatment …

Pulmonary arterial hypertension is a rare but progressive disease that leads to death.
Modern drug treatment slows the progression of the disease and prolongs patients' lives, but …

Patients with pulmonary arterial hypertension (PAH) become candidates for lung or lung and
heart transplantation when the maximum specific therapy is no longer effective. The most …

Background Hospital-acquired (HAP) and ventilator-associated pneumonia (VAP) are
important complications early (< 30 days) after lung transplantation (LT). However, current …

The first lung transplant procedure in the world was performed in 1983, while in Japan that
was first accomplished in 1998. Over the following 25 years, lung transplantation has …

STRESZCZENIE Tętnicze nadciśnienie płucne jest chorobą rzadką, ale postępującą i
prowadzącą do zgonu. Nowoczesne leczenie farmakologiczne spowalnia postęp choroby i …

Abstract Purpose of Review This review delineates current diagnostic and management
strategies for pulmonary hypertension due to interstitial lung disease (PH-ILD). Recent …

Abstract Die Lungentransplantation stellt eine Behandlungsmöglichkeit bei
Lungenerkrankungen im Endstadium dar, deren Prognose und Symptomatik auch unter …

Lung transplantation, a complex and lifealtering medical intervention, serves as a beacon of
hope for individuals grappling with end-stage pulmonary diseases. This research embarks …